By API User
Researchers from the University of Sydney and the Centenary Institute have discovered how a promising class of experimental antibiotics disrupts the bacterium that causes tuberculosis (TB), paving the way for urgently needed new treatments. Globally, TB remains a major health crisis, claiming around 1.2 million lives each year and ranking among the world’s deadliest … Continued
By API User
Clinical practice guidelines specifically for young Australians with bowel cancer to be funded by Bowel Cancer Australia and developed in collaboration with the Australian Living Evidence Collaboration. Bowel Cancer Australia is seeking Expressions of Interest from people with a lived experience of early-onset bowel cancer, healthcare professionals and researchers to be involved in guideline development. … Continued
By API User
Media release 27th February 2026 As the Early Drug Diversion Initiative (EDDI) turns two, the people of NSW still await meaningful changes to our drug laws With the two-year birthday of the Early Drug Diversion Initiative (EDDI) coming into effect in NSW, and 14 months on from the NSW Drug Summit, drug reform … Continued
By API User
Transformative clinical pipeline transaction will add CL-273, a pan-EGFR inhibitor, and CL-741, a Phase 1-Ready c-MET inhibitor, to Kairos Pharma’s clinical portfolio to target multi-billion dollar lung cancer market. LOS ANGELES–BUSINESS WIRE– Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces the signing of a term sheet … Continued
By API User
Total global revenues of $1.5 billion and $5.3 billion for the fourth quarter and full year, increases of 33% and 40% from the prior-year periods Global BRUKINSA (zanubrutinib) revenues of $1.1 billion and $3.9 billion for the fourth quarter and full year, increases of 38% and 49% from the prior-year periods Diluted GAAP Earnings per … Continued
By API User
The Australian Primary Health Care Nurses Association (APNA) warmly welcomes the recommendation of the Senate Community Affairs Committee that the Senate pass the Health Legislation Amendment (Prescribing of Pharmaceutical Benefits) Bill 2025. The Senate Committee report is a significant step in the journey towards allowing authorised registered nurse prescribers to prescribe under the Pharmaceutical Benefits Scheme (PBS). APNA President Denise Lyons … Continued
By API User
Key Facts: The TSANZSRS Annual Scientific Meeting 2026 will be held in Perth from 27-31 March, focusing on two themes: Lungs Under the Microscope and Breathing Through the Ages The five-day conference features international experts from the UK, US, Spain, Sweden, and Brazil, alongside Australian and New Zealand specialists The programme includes plenary sessions, workshops, … Continued
By API User
Rising rates of breast cancer among working-age Australian women have prompted urgent calls for action to address the growing impact of financial toxicity. Financial toxicity describes the negative impact of out-of-pocket costs, indirect costs and the changing financial circumstances of an individual and their household due to cancer, affecting decisions which can lead to suboptimal … Continued
By API User
MEDIA ALERT Thursday 26 February 2026 Pollies, Lifeguards and Local Legends Take the Plunge and Pound the Pavement for Lifeline From 9.00am Friday 27 February | Clovelly Beach Politicians will swap parliamentary dress for cossies and runners this Friday in the 24-Hour Lifeguards for Life Challenge, as leaders, lifeguards and local legends take the plunge … Continued
By API User
Australia’s retirement living sector is increasingly at the forefront of practical solutions to help relieve pressure on hospitals and an aged care system under strain, with co-located retirement villages and aged care facilities offering a pathway to reduce bed-blocking and support older Australians to age in place. Keyton Chief Executive Officer Nathan Cockerill said the … Continued
